Gallant Therapeutics: Funding, Investors & Team (Oct 2026)
Gallant Therapeutics is a biotech company in the field of animal health that specializes in developing stem cell therapies from their stem cell platform. They focus on creating off-the-shelf treatments that can be readily used. Additionally, Gallant is a leading provider of non-invasive stem cell banking services during the spay or neuter process, which allows for new and innovative regenerative medical treatments for animals. Clinical studies have shown the effectiveness of their stem cell therapies in treating various conditions such as osteoarthritis, atopic dermatitis, chronic kidney disease, and chronic stomatitis. One of their products specifically targets chronic gingivostomatitis in cats, providing a life-saving solution. They also have plans to develop a wide range of treatments for companion animals in the future.
Gallant Therapeutics has raised $15.0M across 1 funding round on record, the most recent a Series A of $15.0M announced in Jan 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gallant Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Gallant Therapeutics Funding Rounds
Gallant Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Gallant Therapeutics Funding Compared to Other Biotechnology Startups
Gallant Therapeutics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gallant Therapeutics in Biotechnology and San Diego
Companies Similar to Gallant Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Gallant Therapeutics Funding FAQs
What does Gallant Therapeutics do?
Gallant Therapeutics is a biotech company in the field of animal health that specializes in developing stem cell therapies from their stem cell platform. They focus on creating off-the-shelf treatments that can be readily used. Additionally, Gallant is a leading provider of non-invasive stem cell banking services during the spay or neuter process, which allows for new and innovative regenerative medical treatments for animals. Clinical studies have shown the effectiveness of their stem cell therapies in treating various conditions such as osteoarthritis, atopic dermatitis, chronic kidney disease, and chronic stomatitis. One of their products specifically targets chronic gingivostomatitis in cats, providing a life-saving solution. They also have plans to develop a wide range of treatments for companion animals in the future.
How much funding has Gallant Therapeutics raised?
Gallant Therapeutics has raised $15.0M across 1 round on record. The most recent is a Series A of $15.0M announced in Jan 2024.
When did Gallant Therapeutics last raise funding?
Gallant Therapeutics' most recent funding round on record is a Series A of $15.0M, announced in Jan 2024.
Who founded Gallant Therapeutics?
FundedIQ lists Linda Black (Founder) at Gallant Therapeutics.
Where is Gallant Therapeutics headquartered?
Gallant Therapeutics is based in San Diego, California, United States.
How many employees does Gallant Therapeutics have?
Gallant Therapeutics is in the 11-50 employee band.
How does Gallant Therapeutics' funding compare to other Biotechnology startups?
Gallant Therapeutics' latest round of $15.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Gallant Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gallant Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.